Učitavanje...
Insulin degludec/insulin aspart in Japanese patients with type 1 diabetes mellitus: Distinct prandial and basal glucose‐lowering effects
AIMS/INTRODUCTION: Insulin degludec/insulin aspart (IDegAsp) is a soluble co‐formulation of long‐acting insulin degludec (IDeg) and rapid‐acting insulin aspart (IAsp). The present study investigated the pharmacodynamic properties of IDegAsp in Japanese patients with type 1 diabetes mellitus. MATERIA...
Spremljeno u:
| Izdano u: | J Diabetes Investig |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4931208/ https://ncbi.nlm.nih.gov/pubmed/27181070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12461 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|